AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: VANDERBOM JG BOTS ML HAVERKATE F MEIJER P KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., ACTIVATION PRODUCTS OF THE HEMOSTATIC SYSTEM IN CORONARY, CEREBROVASCULAR, AND PERIPHERAL ARTERIAL-DISEASE, Thrombosis and haemostasis, 1997, pp. 537-537

Authors: VANDERBOM JG BOTS ML SLAGBOOM PE HAVERKATE F MEIJER P KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., THE RISK OF SMOKING IS MODIFIED BY THE 4G ALLELE OF THE PAI-1 GENE, Thrombosis and haemostasis, 1997, pp. 2366-2366

Authors: MEIJER P BRUSSAARD HE KRANS HMJ KLUFT C
Citation: P. Meijer et al., THE EFFECT OF ESTROGEN-TREATMENT ON FACTOR-VII IN POSTMENOPAUSAL WOMEN WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Thrombosis and haemostasis, 1997, pp. 3015-3015

Authors: KLUFT C MEIJER P BRUSSAARD HE KRANS HMJ SCHUIT AJ
Citation: C. Kluft et al., SERUM NEOPTERIN IN ACUTE CORONARY SYNDROMES, Lancet, 349(9060), 1997, pp. 1253-1253

Authors: VANDERBOM JG DEKNIJFF P HAVERKATE F BOTS ML MEIJER P DEJONG PTVM HOFMAN A KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., TISSUE-PLASMINOGEN ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION - THE ROTTERDAM STUDY, Circulation, 95(12), 1997, pp. 2623-2627

Authors: BRULS E VERSTRAELEN M ZWEMSTRA T MEIJER P
Citation: E. Bruls et al., ANALOG FAULT SIMULATION IN STANDARD VHDL, IEE proceedings. Circuits, devices and systems, 143(6), 1996, pp. 380-385

Authors: DEMAAT MPM DEBART ACW HENNIS BC MEIJER P HAVELAAR AC MULDER PGH KLUFT C
Citation: Mpm. Demaat et al., INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIABILITY IN PLASMA-FIBRINOGEN,TPA ANTIGEN, PAI ACTIVITY, AND CRP IN HEALTHY, YOUNG VOLUNTEERS AND PATIENTS WITH ANGINA-PECTORIS, Arteriosclerosis, thrombosis, and vascular biology, 16(9), 1996, pp. 1156-1162

Authors: MEIJER P KLUFT C
Citation: P. Meijer et C. Kluft, CRITERIA FOR A SPECIFIC PLASMIN INHIBITION TEST (SPIT) IN HUMAN PLASMA, Fibrinolysis, 10, 1996, pp. 121-123

Authors: MEIJER P VANDERHAM F KLUFT C
Citation: P. Meijer et al., THE USE OF STABILYTE(R) PLASMA MAY CAUSE CHANGES IN PH IN THE ASSAY OF SOME FIBRINOLYSIS ANALYTES AND MIGHT EFFECT RESULTS, Fibrinolysis, 10, 1996, pp. 155-157

Authors: BOTS ML VANDERBOM JG HAVERKATE F MEIJER P HOFMAN A GROBBEE DE KLUFT C
Citation: Ml. Bots et al., ACTIVATED PROTEIN-C RESPONSE AND CARDIOVASCULAR RISK-FACTORS IN THE ELDERLY - THE ROTTERDAM STUDY, Fibrinolysis, 10, 1996, pp. 161-164

Authors: CLASON SB MEIJER P KLUFT C ERSDAL E
Citation: Sb. Clason et al., A NOVEL METHOD, COAMATIC(R) PLASMIN INHIBITOR, FOR THE SPECIFIC DETERMINATION OF PLASMIN INHIBITOR ACTIVITY IN PLASMA, Fibrinolysis, 10, 1996, pp. 165-167

Authors: KLUFT C MEIJER P
Citation: C. Kluft et P. Meijer, UPDATE 1996 - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENTOF PLASMINOGEN ACTIVATORS AND INHIBITORS (LEIDEN FIBRINOLYSIS WORKSHOP), Fibrinolysis, 10, 1996, pp. 171-179

Authors: HAFFMANS PMJ TIMMERMAN L HOOGDUIN CAL VANLAARHOVEN JHM VANGOOL AR COPPENS JMG WINTER R SCHMIDT R DIJKSTRA HN QUERIDO AL OFFERMANS JMJF FORTUYN HAD FIOLET J LIGTENBERG HH VENEMA HCP ZWARTJES GC VANLANGEVELDE AM BATELAAN B NOTTEN P BOOM AJ DEKKER D ELAND W MEIJER P VANBEUZEKOM C DRIES P KABELA M NOORDANUS WJ
Citation: Pmj. Haffmans et al., EFFICACY AND TOLERABILITY OF CITALOPRAM IN COMPARISON WITH FLUVOXAMINE IN DEPRESSED OUTPATIENTS - A DOUBLE-BLIND, MULTICENTER STUDY, International clinical psychopharmacology, 11(3), 1996, pp. 157-164

Authors: VANDERBOM JG BOTS ML HAVERKATE F SLAGBOOM PE MEIJER P DEJONG PTVM HOFMAN A GROBBEE DE KLUFT C
Citation: Jg. Vanderbom et al., REDUCED RESPONSE TO ACTIVATED PROTEIN-C IS ASSOCIATED WITH INCREASED RISK FOR CEREBROVASCULAR-DISEASE, Annals of internal medicine, 125(4), 1996, pp. 265

Authors: MEIJER P KLUFT C
Citation: P. Meijer et C. Kluft, CRITERIA FOR SPECIFIC, AUTOMATED ALPHA(2)-ANTIPLASMIN ACTIVITY MEASUREMENT IN PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1145-1145

Authors: VANDERBOM JG KLUFT C BOTS ML HAVERKATE F SLAGBOOM E MEIJER P GROBBCE DE
Citation: Jg. Vanderbom et al., FACTOR-V MUTATION, APC RESISTANCE AND MYOCARDIAL-INFARCTION IN THE ROTTERDAM STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1373-1373

Authors: TWISK J HOEKMAN MFM LEHMANN EM MEIJER P MAGER WH PRINCEN HMG
Citation: J. Twisk et al., INSULIN SUPPRESSES BILE-ACID SYNTHESIS IN CULTURED RAT HEPATOCYTES BYDOWN-REGULATION OF CHOLESTEROL 7-ALPHA-HYDROXYLASE AND STEROL 27-HYDROXYLASE GENE-TRANSCRIPTION, Hepatology, 21(2), 1995, pp. 501-510

Authors: MEIJER P
Citation: P. Meijer, UNTITLED - REPLY, Fibrinolysis, 9(2), 1995, pp. 130-131

Authors: VELTHUISTEWIERIK EJM MEIJER P KLUFT C VANDENBERG H
Citation: Ejm. Velthuistewierik et al., BENEFICIAL EFFECT OF A MODERATELY ENERGY-RESTRICTED DIET ON FIBRINOLYTIC FACTORS IN NONOBESE MEN, Metabolism, clinical and experimental, 44(12), 1995, pp. 1548-1552

Authors: BRUSSAARD HE LEUVEN JAG KRANS HMJ MEIJER P BUYTENHEK R KLUFT C
Citation: He. Brussaard et al., NONESTERIFIED FATTY-ACIDS ARE RELATED WITH HYPOFIBRINOLYSIS IN TYPE-2DIABETES-MELLITUS, Fibrinolysis, 8, 1994, pp. 25-27

Authors: MEIJER P KAMERLING SWA VANDEHAM FJ KRET R KLUFT C KRAUS J WAGNER C
Citation: P. Meijer et al., BASE-LINE LEVELS OF ALPHA(2)-ANTIPLASMIN-PLASMIN COMPLEX IN HUMAN PLASMA, Fibrinolysis, 8, 1994, pp. 124-125

Authors: NAGEL A MEIJER P LOS P KLUFT C
Citation: A. Nagel et al., SOME CHARACTERISTICS OF COMMERCIALLY AVAILABLE HUMAN GLU-PLASMINOGEN PREPARATIONS, Fibrinolysis, 8, 1994, pp. 135-137

Authors: MEIJER P KRET R BLOETJES PTM ROSEN S KLUFT C
Citation: P. Meijer et al., NEW ASPECTS OF BLOOD COLLECTION AND HANDLING PROCEDURES FOR THE ASSESSMENT OF T-PA AND PAI-1 VARIABLES AFTER THE INTRODUCTION OF ACID BLOODCOLLECTION, Fibrinolysis, 8, 1994, pp. 145-147

Authors: MEIJER P WESTERVELD W HUISMAN LGM
Citation: P. Meijer et al., AN IMPROVED METHOD FOR THE DETECTION OF ALPHA(2)-ANTIPLASMIN ACTIVITYON THE AUTOMATED COAGULATION ANALYZER MLA ELECTRA 1000C, Fibrinolysis, 8, 1994, pp. 160-162

Authors: MEIJER P POLLET DE WAUTERS J KLUFT C
Citation: P. Meijer et al., SPECIFICITY OF ANTIGEN ASSAYS OF PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA - INNOTEST PAI-1 IMMUNOASSAY EVALUATED, Clinical chemistry, 40(1), 1994, pp. 110-115
Risultati: 1-25 | 26-34